In hepatocarcinogenesis, the TGF-β effector SMAD4 appears to control the transcription of miR-181b [15], whereas TGF-β induces miR-181a/b at the post-transcriptional level through SMAD2/3-dependent miRNA maturation in breast cancer [16]. The gene discussed is SMAD2; the disease is breast carcinoma.